Concomitant medications and efficacy of nintedanib in patients with IPF
Michael Kreuter, Jin Woo Song, John T. Huggins, Benoit Wallaert, Wibke Stansen, Manuel Quaresma, Bruno Crestani
European Respiratory Journal 2017 50: PA4891; DOI: 10.1183/1393003.congress-2017.PA4891
Michael Kreuter
1Center for interstitial and rare lung diseases, Pneumology, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
Jin Woo Song
2ASAN Medical Center, Seoul, Republic of Korea
John T. Huggins
3Medical University of South Carolina, Charleston, South Carolina, United States of America
Benoit Wallaert
4University Hospital of Lille, Lille, France
Wibke Stansen
5Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
Manuel Quaresma
6Center for interstitial and rare lung diseases, Pneumology, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg, German Center for Lung Research; and Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
Bruno Crestani
7Hôpital Bichat, Pneumologie, Paris, France
Vol 50 Issue suppl 61
Table of Contents
Concomitant medications and efficacy of nintedanib in patients with IPF
Michael Kreuter, Jin Woo Song, John T. Huggins, Benoit Wallaert, Wibke Stansen, Manuel Quaresma, Bruno Crestani
European Respiratory Journal Sep 2017, 50 (suppl 61) PA4891; DOI: 10.1183/1393003.congress-2017.PA4891